KDM5B and cancer: JARID1B (Jumonji AT-rich interactive domain 1B) is a histone demethylase that can specifically remove the H3K4me3 mark and inhibit transcription of its related genes, playing an important role in cell fate determination, cancer progression, and stem cell self-renewal role [104].